- Research works
- 29 ▲ 103% vs 2013–17
- Citations
- 585 19.9 per fractional work
- Top-10% rate
- 3.5% record average 16.5%
- Open access
- 27% world 28%
Not ranked overall: Palatin Technologies (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 20.5×. Every wedge is a field page.
Which keywords describe research at Palatin Technologies (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Cardiovascular Disease, Menopause, Erectile Dysfunction, Sexual Dysfunction, Metabolic Syndrome, Hormone Therapy, Diabetes and Aging Men.
- Hypertension
- Big Data
- PET Imaging
- Immune Response
- Depression
- Epidemiology
- Genetics
- Leptin
- Hormonal Regulation
- Testosterone
- Inflammation
- Hormone Therapy
- Sexual Dysfunction
- Menopause
- Cardiovascular Disease
- Erectile Dysfunction
- Metabolic Syndrome
- Diabetes
- Aging Men
- Obesity
- Ghrelin
- Neural Circuits
- Cytokines
- T Cell Activation
- Atherosclerosis
- Angiogenesis
- Treatment
- Cytochrome P450
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 28 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 28 words, with their numbers
- Cardiovascular Disease6▲ 18×7 topics
- Menopause5▲ 356×2 topics
- Erectile Dysfunction4▲ 503×1 topic
- Sexual Dysfunction4▲ 503×1 topic
- Metabolic Syndrome4▲ 16×6 topics
- Hormone Therapy4▲ 120×2 topics
- Diabetes3▲ 20×2 topics
- Inflammation3▲ 4.5×9 topics
- Aging Men3▲ 233×1 topic
- Testosterone3▲ 154×1 topic
- Obesity3▲ 13×5 topics
- Hormonal Regulation2▲ 154×2 topics
- Ghrelin2▲ 174×1 topic
- Leptin2▲ 174×1 topic
- Neural Circuits2▲ 41×2 topics
- Genetics2▲ 7.5×5 topics
- Cytokines2▲ 19×3 topics
- Epidemiology1▲ 1.19×6 topics
- T Cell Activation1▲ 97×2 topics
- Depression1▲ 6.1×4 topics
- Atherosclerosis1▲ 11×1 topic
- Immune Response1▲ 6.5×1 topic
- Angiogenesis1▲ 9.6×3 topics
- PET Imaging1▲ 17×2 topics
- Treatment1▲ 2.9×3 topics
- Big Data1▲ 6.5×4 topics
- Cytochrome P4501▲ 47×2 topics
- Hypertension1▲ 9.6×2 topics
Which research topics does Palatin Technologies (United States) publish most on?
By volume in 2022–2025: Atherosclerosis and Cardiovascular Diseases, Big Data and Business Intelligence, Cloud Computing and Resource Management and Human-Automation Interaction and Safety.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Atherosclerosis and Cardiovascular Diseases Immunology 1 works
- 2 Big Data and Business Intelligence Management Information Systems 0 works
- 3 Cloud Computing and Resource Management Information Systems 0 works
- 4 Human-Automation Interaction and Safety Social Psychology 0 works
- 5 Blockchain Technology Applications and Security Information Systems 0 works
- 6 Inflammatory Bowel Disease Genetics 0 works
- 7 AI in Service Interactions Artificial Intelligence 0 works
- 8 Ethics and Social Impacts of AI Safety Research 0 works
- 9 Regulation of Appetite and Obesity Endocrine and Autonomic Systems 0 works
- 10 Adipokines, Inflammation, and Metabolic Diseases Epidemiology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Palatin Technologies (United States)'s research output changed?
Output in 2018–2022 was 103% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Cranbury
- Princeton Lightwave (United States)
- Amicus Therapeutics (United States)
- Eternity Bioscience (United States)
- Crystal Pharmatech (United States)
- VaxInnate (United States)
- Nano-Ditech (United States)
- Robert Miller Consulting
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.